Nitrik oksit ve nörofizyopatolojik etkileri

TÜRKÖZ, Yusuf; ÖZEROL, İbrahim Halil; ALADAĞ, M. Akif

Nitrik oksit ve nörofizyopatolojik etkileri

M. Akif ALADAĞ, (İnönü Üniversitesi, Tıp Fakültesi, Nöroşirürji Anabilim Dalı, Malatya, Türkiye)

Yusuf TÜRKÖZ, (İnönü Üniv Tıp Fakültesi, Biyokimya Anabilim Dalı, Malatya, Türkiye)

İbrahim Halil ÖZEROL (İnönü Üniversitesi, Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Malatya, Türkiye)

Türkiye Klinikleri Tıp Bilimleri Dergisi

10 0

Yıl: 2000 Cilt: 20 Sayı: 2 Sayfa Aralığı: 107 - 111 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Nitrik oksit ve nörofizyopatolojik etkileri

Öz:

Nitrik oksit (NO), zehirli serbest radikal bir gazdır. Organizmanın bir çok işlevinde ve birçok hastalık durumunda rol alır. Hemen hemen her hücre tarafından üretilir ve her hücre üzerine etkinlik gösterir. Bu nedenle, NO genel aracı bir moleküldür. Diğer serbest oksijen radikalleri her konsantrasyonda zararlı iken, NO düşük konsantrasyonlarda kan basıncı ve sindirim sisteminin düzenlenmesinden konak savunması ve özgül olmayan immüniteye kadar bir çok önemli fizyolojik olayların düzenlenmesinde rol oynar. Ancak, uygunsuz yerde ve aşırı miktarda üretildiğinde, bir çok patolojik durumun ortaya çıkmasına neden olur.

Anahtar Kelime: Nitrik oksit Nitrik oksit sentaz Fizyoloji

Konular: Genel ve Dahili Tıp

Nitric oxide and its neurophysiopathological effects

Öz:

Nitric oxide (NO) is a poisonous free radical gas. It plays a role in many functions of human organism, and in many diseases. NO is produced by almost every cell and has effects on different cells. Therefore, it acts as a general transmitter. While the other free oxygen-radicals are harmful in every concentration, low levels of NO plays regulatory role in many physiological processes such as blood pressure, gastrointestinal system functions, host defence, and nonspesific immunity. However, NO causes many pathological conditions when it is produced at inappropriately localizations and in high quantity

Anahtar Kelime: Physiology Nitric Oxide Nitric Oxide Synthase

Konular: Genel ve Dahili Tıp

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Bibliyografik

1.Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
2.Ignarro LJ, Bugo GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9.
3.Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release account for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-6.
4.Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite; implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
5.Hibbs JBJr. Overview of cytotoxic mechanism, and defence of intracellular environment againts microbeses. In: Moncada S, Marietta MA, Hibbs JB Jr, eds. The biology of nitric oxide: Enzimology, biochemistry and immunology. London: Portland Press. 1992: 2: 201-6.
6.Star RA. Nitric oxide. Am J Med Sci 1993; 306 (5): 348-58.
7.Tayeh MA, Marlette MA. Macrophage oxidation of L-argi-nine to nitric oxide, nitrite and nitrate: Tetrahydrobiopterin is required as cofactor. J Biol Chem 1989; 264: 19654-58.
8.Moncada S, Palmer RMJ, Higgs A. Nitric oxide: Physology, pathophysology, and pharmacology. Pharmacol Reviews 1991; 43 (9): 109-37.
9.Bloch KD, Wolfram JR, Brown DM, Roberts JD Jr, Zapol DG, Lepore JJ, Filippov G, Thomas JE, Jacob HJ, Bloch DB. Three members of the nitric oxide synthase II gene family colocalize to human chromosome 17. Genomic 1995; 27: 526-30.
10.Michel T, Xie QW, Nathan C. Molecular biological analysis of nitric oxide synthases. In: Feefisch M, Stamler JS, eds. Molecular biological analysis of nitric oxide synthases in methods in nitric oxide research. Chichester: Wiley & Sons. 1996: 161-75.
11.Mohaupt MG, Elzie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 1994; 46: 653-65.
12.Busse R, Fleming I, Schini VB. Nitric oxide formation in the vascular Wall: regulation and functional implications. Curr Top Microbial Immunol 1995; 196: 7-18.
13.Marietta MA. Approaches toward selective inhibition of nitric oxide synthase. J Med Chem 1994; 37: 1899-907.
14.Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, controls. Cell 1994; 78: 915-8.
15.Hibbs JB JR, Taintor RR, Vavrin Z, and Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1998; 157: 87-94.
16.Nussler AK, Billiar TR. Inflammation, immunoregulation and inducible nitric oxide synthase. J Leukoc Biol (USA) 1993; 54 (2): 171-8.
17.Moncada S, Higgs A. The L-arginine- nitric oxide pathway N Engl J Med 1993; 329: 2002-12.
18.Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-5.
19.Ignarro LJ. Nitric oxide: A novel signal transduction mechanism for transcellular communication. Hypertension (USA) 1990; 16 (5): 477-83.
20.Snyder SH. Nitric oxide: First in a new class of neurotransmitters. Science 1992; 257: 494-6.
21 .Loscalzo J, Welch G. Nitric oxide and its role in the cardio-vasculer system. Prog Cardiovasc Dis (USA) 1995; 38 (2): 87-104.
22.Calver A, Collier J, Moncada S, Vallence P. Effect of local intra-arterial NG-monomethyl -L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025-31.
23.Luscher TF. Endothelium-derived nitric oxide; the endogenous nitrovasodilatator in the human cardiovascular system. Eur Heart J 1991; 12: (Suppl E): 2-11.
24.Sogni P, Moreau R, Ohsuga M, Cailmail SiOberti F, Hadengue A, Pussard E, Librec D. Evidence for normal nitric oxide-mediated vasodilator tone in cirrchosis. Hepatology 1992; 16: 980-3.
25.Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
26.Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 1996; 47: 365-75.
27.Klebanoff SJ. Oxygen metabolites from phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic principles and clinical correlates. New York: Raven. 1992:541-88.
28.De Graaf JC, Banga JD, Moncada S, Palmer RM, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulations 1992; 85: 2284-90.
29.Redomski MW, Palmer RMS, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-58.
30.Redomski MW, Palmer RMS, Moncada S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br J Pharmacol 1990; 101: 325-8.
31.Varela AF, Runge A, Ignarro LJ, Chaudhuri G. Nitric oxide and prostacycline inhibit fetal platelet aggregation; a response similar to that observed in adults. Am J Obstet Gynecol 1992; 167: 1599-604.
32.Garthwaite J. Glutamate nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci.1991; 14: 60-7.
33.Garthwaite J, Boulton CL. Nitric oxide signalling in the central nervous system. Annu Rev Physiol 1995; 57: 683-706.
34.Snyder SH, Bredt DS. Biological roles of nitric oxide. Sci Am 1992; 266:68-71.
35.01esen J, Thomsen LL, iversen H.- Nitric oxide is a key molecule in migraine and other vascular headaches. Trend Pharmacol Sci (England) 1994; 15 (5):149-53.
36.Gillespie JS, Lyu X, Martin W. The neurotransmitter of the non-adrenergic non- cholinergic inhibitory nerves to smooth muscle of the genital system. In: Moncada S, Higgs EA, eds. Nitric oxide from L-arginine: A bioregulatory system. Amsterdam: Elsevier Science Publisher BV, 1990:147-64.
37.Rand M J. Nitrergic transmission; nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol 1992; 19:147-69.
38.Toda N. Nitric oxide and the regulation of cerebral arterial tone. In: Vincent S, ed. Nitric oxide in the nervous system. Orlando: Academic Press Ltd. 1995: 207-55.
39.Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitrice oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 1991; 88: 7797-801.
40.Tottrup A, Glavihd EB, Svane D. Involvement of the L-arginine-nitric oxide pathway in internal anal sphincter relaxation. Gastroentrology 1992; 102: 409-15.
41.Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penil erection. Sciene 1992; 257: 401-3.
42.Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as mediator of the corpus cavernosum in response to non-adrenergic non-cholinergic transmission. N Engl J Med 1992; 326: 90-4.
43.Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA. Nitric oxide synthase, inhibition and cerebro-vascular regulation. J Cereb Blood Flow Metab 1994; 14: 175-92.
44.Dawson VL, Dawson TM, Uhl GR. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993; 90: 3256-59,
45.Kong LY, Wilson BC, Mc Millian MK, Bing G, Hudson PM, Hong JS. The effects of the HIV-1 envelope protein gpl20 on the protein on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 1996; 172: 77-83.
46.Bo L, Dawson TM, Weselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD. Induction of nitric oxide synthase in demyelinating region of multiple sclerosis brains. Ann Neurol 1994; 36: 778-86.
47.Visser JJ, Scholten RJPM, Hoekman K. Nitric oxide synthesis in meningococcal meningitis. Ann Int Med 1994; 120: 345-6.
48.Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 1994; 14: 5147-59.
49.Dawson TM, Dawson VL. Nitric oxide: actions and pathological roles. Neuroscientist 1995; 1: 7-18.
50.Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease Trends Pharmacol Sci 1990;, 11: 379-87.
51 .Oury TD, Ho YS, Piantadosi CA,Crapo JD. Extracellular superoxide dismutase, nitric oxide, and central nervous system 02 toxicity. Proc Natl Acad Sci USA 1992; 89: 9715-19.
52.Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 151: 2132-41.
53.Thomsen LL, iversen HK, Brinck TA. Arterial supersensiv-ity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 1993; 13: 395-99.
54.Kamijo RH, Harada T, Matsuyama M, Bosland J, Gerecitano D, Shapiro J, Le SI, Koh T, Kimura SJ, Green TW, Mai ST. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263: 1612-15.
55.Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120: 227-37.
56.Keller R. The macrophage response to infectious agents; mechanism of macrophage activation and tumour cell killing. Res Immunol 1993; 144: 271-73.
57.Farias-Eisner R, Sherman MP, Aerberhard E, Chaudhuri G. Nitric oxide is an important mediator of tumorocidial activity in vivo. Proc Natl Acad Sci USA 1994; 91: 9407-11.
58.Adler HJ, Beland JL, Del-Pan NC, Kobzik L, Brewer JP, Martin TR, Rimm U. Suppression of herpes simplex virus type 1 (HSV-1) induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med 1997;185: 1533-40.
59.Akaike TI, Weihe M, Schafer M, Fu ZF, Zhang YM, Vogel W, Schmidh H. Effect of neurotropia virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J Neurovirol 1995;1: 118-25.
60.Staebeli P. Interferon-Inducible proteins and the antiviral state. Adv Virus Res 1990;38: 147-200.
61.McInnes IB, Leung BP, Field M, Wei XO, Hueng FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996; 184:1519-24.
62.StClair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeron GS. Rheumatoid arthritis patients have increased expression of blood mononuclear cell nitric oxide synthase type 2. J Exp Med 1996; 184:1173-8.
63.Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity Arthritis Rheum 1998; 41: 1141.

APA	ALADAĞ M, TÜRKÖZ Y, ÖZEROL İ (2000). Nitrik oksit ve nörofizyopatolojik etkileri. , 107 - 111.
Chicago	ALADAĞ M. Akif,TÜRKÖZ Yusuf,ÖZEROL İbrahim Halil Nitrik oksit ve nörofizyopatolojik etkileri. (2000): 107 - 111.
MLA	ALADAĞ M. Akif,TÜRKÖZ Yusuf,ÖZEROL İbrahim Halil Nitrik oksit ve nörofizyopatolojik etkileri. , 2000, ss.107 - 111.
AMA	ALADAĞ M,TÜRKÖZ Y,ÖZEROL İ Nitrik oksit ve nörofizyopatolojik etkileri. . 2000; 107 - 111.
Vancouver	ALADAĞ M,TÜRKÖZ Y,ÖZEROL İ Nitrik oksit ve nörofizyopatolojik etkileri. . 2000; 107 - 111.
IEEE	ALADAĞ M,TÜRKÖZ Y,ÖZEROL İ "Nitrik oksit ve nörofizyopatolojik etkileri." , ss.107 - 111, 2000.
ISNAD	ALADAĞ, M. Akif vd. "Nitrik oksit ve nörofizyopatolojik etkileri". (2000), 107-111.

APA	ALADAĞ M, TÜRKÖZ Y, ÖZEROL İ (2000). Nitrik oksit ve nörofizyopatolojik etkileri. Türkiye Klinikleri Tıp Bilimleri Dergisi, 20(2), 107 - 111.
Chicago	ALADAĞ M. Akif,TÜRKÖZ Yusuf,ÖZEROL İbrahim Halil Nitrik oksit ve nörofizyopatolojik etkileri. Türkiye Klinikleri Tıp Bilimleri Dergisi 20, no.2 (2000): 107 - 111.
MLA	ALADAĞ M. Akif,TÜRKÖZ Yusuf,ÖZEROL İbrahim Halil Nitrik oksit ve nörofizyopatolojik etkileri. Türkiye Klinikleri Tıp Bilimleri Dergisi, vol.20, no.2, 2000, ss.107 - 111.
AMA	ALADAĞ M,TÜRKÖZ Y,ÖZEROL İ Nitrik oksit ve nörofizyopatolojik etkileri. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2000; 20(2): 107 - 111.
Vancouver	ALADAĞ M,TÜRKÖZ Y,ÖZEROL İ Nitrik oksit ve nörofizyopatolojik etkileri. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2000; 20(2): 107 - 111.
IEEE	ALADAĞ M,TÜRKÖZ Y,ÖZEROL İ "Nitrik oksit ve nörofizyopatolojik etkileri." Türkiye Klinikleri Tıp Bilimleri Dergisi, 20, ss.107 - 111, 2000.
ISNAD	ALADAĞ, M. Akif vd. "Nitrik oksit ve nörofizyopatolojik etkileri". Türkiye Klinikleri Tıp Bilimleri Dergisi 20/2 (2000), 107-111.